Sangeeta Umesh Nayak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sangeeta Umesh Nayak has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
Ashita Uppoor
Department of Periodontology, Manipal College of Dental Sciences Mangalore, Manipal Academy of Higher Education, Manipal, Mangalore, Karnataka, 575001
4 shared publications- Ashita Uppoor
Department of Periodontology, Manipal College of Dental Sciences Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, India
4 shared publications Aradhya Sinha
Department of Periodontology, Manipal College of Dental Sciences Mangalore, Manipal Academy of Higher Education, Manipal, Mangalore, Karnataka, 575001
3 shared publications- David Kadakampally
Deptment of Periodontology, Manipal College of Dental Sciences Mangalore, Manipal Academy of Higher Education, Manipal, India
2 shared publications Deepa G. Kamath
Department of Periodontology, Manipal College of Dental Sciences Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka 575001, India
2 shared publications- Mranali K. Shetty
Department of Periodontology, Manipal College of Dental Sciences Mangalore, Manipal Academy of Higher Education, Manipal 576104, India
2 shared publications
Latest Publications
- Open Access
- 8 October 2026
- Published by Springer Nature in BMC Oral Health
Clinical efficacy of hydrogen peroxide-based mouthwash versus chlorhexidine in post-periodontal flap surgery healing: a randomized controlled clinical trial
Background: Postsurgical wound healing following periodontal flap surgery is critical for achieving optimal clinical outcomes. While chlorhexidine (CHX) remains the gold standard antiseptic mouthwash, concerns regarding adverse effects have prompted the exploration of alternative agents. A novel hydrogen peroxide-based formulation containing lactoferrin and zinc lactate may offer comparable efficacy with improved safety profiles. Methods: To compare the clinical efficacy of a hydrogen peroxide-based mouthwash (Freshchlor Plus-Group Pharmaceuticals India) containing 0.1% H₂O₂, 0.05% lactoferrin, and 0.14% zinc lactate versus 0.12% chlorhexidine (Group Pharmaceuticals India) on wound healing outcomes, patient-reported outcome measures (PROMs), and adverse reactions following periodontal flap surgery.This single-center, randomized, double-blind, parallel-design clinical trial included 32 systemically healthy adults who underwent periodontal flap surgery. Participants were randomly allocated to either Group A (0.12% CHX, n = 16) or Group B (Freshchlor Plus, n = 16). Both groups were rinsed with 10 mL of the assigned mouthwash for 60 s twice daily for 14 days. Primary outcomes included Wound Healing Index (WHI) scores assessed on days 3, 7, and 14. Secondary outcomes included pain intensity measured using the visual analogue scale (VAS), analgesic consumption, and adverse reactions. Statistical analyses included the Mann‒Whitney U test, chi‒square test, and descriptive statistics, with significance set at p < 0.05. Results: Both groups demonstrated excellent wound healing, with no statistically significant differences in WHI scores on day 3 (Group A: 1.25 ± 0.58 vs. Group B: 1.07 ± 0.250; p = 0.325), day 7 (Group A: 1.19 ± 0.54 vs. Group B: 1.07 ± 0.26; p = 0.59), or day 14 (both groups: 1.00 ± 0.000). Pain levels remained minimal in both groups, with 96.9% of participants reporting VAS scores of 0–4 mm at all time points. Analgesic consumption was comparable between the groups ( p = 0.545). However, adverse reactions differed significantly ( p = 0.046), with Group B exhibiting fewer adverse events (6.2% vs. 37.5%). Notably, tooth staining occurred exclusively in Group A (31.3%). Conclusion: The hydrogen peroxide-, lactoferrin-, and zinc-containing mouthwash demonstrated favorable early postoperative healing and was associated with fewer reported adverse effects than 0.12% chlorhexidine, while no significant between-group difference was observed in the primary wound-healing outcome. These findings suggest that the formulation may be a promising alternative for short-term postoperative oral care following periodontal flap surgery; however, larger, adequately powered multicenter trials with longer follow-up and objective microbiological and adherence assessments are needed to confirm these findings. Trial Registration: Clinical Trials Registry-India (CTRI), CTRI/2025/10/096090, registered on 15 October 2025. Prospectively registered.
- 8 October 2026
- Published by Springer Nature in BMC Oral Health
Open AccessClinical efficacy of hydrogen peroxide-based mouthwash versus chlorhexidine in post-periodontal flap surgery healing: a randomized controlled clinical trial
Background: Postsurgical wound healing following periodontal flap surgery is critical for achieving optimal clinical outcomes. While chlorhexidine (CHX) remains the gold standard antiseptic mouthwash, concerns regarding adverse effects have prompted the exploration of alternative agents. A novel hydrogen peroxide-based formulation containing lactoferrin and zinc lactate may offer comparable efficacy with improved safety profiles. Methods: To compare the clinical efficacy of a hydrogen peroxide-based mouthwash (Freshchlor Plus-Group Pharmaceuticals India) containing 0.1% H₂O₂, 0.05% lactoferrin, and 0.14% zinc lactate versus 0.12% chlorhexidine (Group Pharmaceuticals India) on wound healing outcomes, patient-reported outcome measures (PROMs), and adverse reactions following periodontal flap surgery.This single-center, randomized, double-blind, parallel-design clinical trial included 32 systemically healthy adults who underwent periodontal flap surgery. Participants were randomly allocated to either Group A (0.12% CHX, n = 16) or Group B (Freshchlor Plus, n = 16). Both groups were rinsed with 10 mL of the assigned mouthwash for 60 s twice daily for 14 days. Primary outcomes included Wound Healing Index (WHI) scores assessed on days 3, 7, and 14. Secondary outcomes included pain intensity measured using the visual analogue scale (VAS), analgesic consumption, and adverse reactions. Statistical analyses included the Mann‒Whitney U test, chi‒square test, and descriptive statistics, with significance set at p < 0.05. Results: Both groups demonstrated excellent wound healing, with no statistically significant differences in WHI scores on day 3 (Group A: 1.25 ± 0.58 vs. Group B: 1.07 ± 0.250; p = 0.325), day 7 (Group A: 1.19 ± 0.54 vs. Group B: 1.07 ± 0.26; p = 0.59), or day 14 (both groups: 1.00 ± 0.000). Pain levels remained minimal in both groups, with 96.9% of participants reporting VAS scores of 0–4 mm at all time points. Analgesic consumption was comparable between the groups ( p = 0.545). However, adverse reactions differed significantly ( p = 0.046), with Group B exhibiting fewer adverse events (6.2% vs. 37.5%). Notably, tooth staining occurred exclusively in Group A (31.3%). Conclusion: The hydrogen peroxide-, lactoferrin-, and zinc-containing mouthwash demonstrated favorable early postoperative healing and was associated with fewer reported adverse effects than 0.12% chlorhexidine, while no significant between-group difference was observed in the primary wound-healing outcome. These findings suggest that the formulation may be a promising alternative for short-term postoperative oral care following periodontal flap surgery; however, larger, adequately powered multicenter trials with longer follow-up and objective microbiological and adherence assessments are needed to confirm these findings. Trial Registration: Clinical Trials Registry-India (CTRI), CTRI/2025/10/096090, registered on 15 October 2025. Prospectively registered.
- Open Access
- 7 October 2026
- Published by Spandidos Publications in World Academy of Sciences Journal
- Vol. 8 (6) , 1-10
GLP‑1 receptor agonists and their dental implications: A practical guide for dental practitioners (Review)
Glucagon‑like peptide‑1 receptor agonists (GLP‑1RAs) have revolutionized the management of type 2 diabetes mellitus and obesity. Their rapidly increasing use has critical implications for dental practice, yet guidance for clinicians remains limited. The aim of the present review was to provide an evidence‑based narrative summary of the oral and dental implications of GLP‑1RA therapy and to provide practical chair‑side recommendations for dental practitioners. For this purpose, a narrative literature review was performed to synthesize current evidence concerning the oral, periodontal and perioperative implications of GLP‑1RAs in dental practice. The PubMed/MEDLINE, Scopus, Web of Science and Google Scholar databases were searched for publications from January, 2015 through June, 2026. As this was a narrative review, studies were selected according to their clinical relevance and contribution to the mechanistic and practical questions addressed rather than according to a predefined systematic review protocol. No PRISMA flow diagram or quantitative study‑selection estimates were therefore applied. Particular emphasis was placed on distinguishing established clinical evidence from observational associations, preclinical findings and mechanistic hypotheses. Current evidence suggests that GLP‑1RAs may contribute to xerostomia, dysgeusia, halitosis and dental erosion, largely secondary to adverse gastrointestinal effects and salivary alterations. Conversely, improved glycemic control may favor periodontal health and wound healing. Delayed gastric emptying has critical implications for dental procedures requiring sedation or general anesthesia and necessitates careful preoperative assessment and interdisciplinary communication. On the whole, as the number of prescriptions of GLP‑1RAs continues to expand, dental practitioners should routinely identify affected patients, recognize potential oral manifestations, implement preventive strategies and consider perioperative implications to optimize patient safety and clinical outcomes.
- 7 October 2026
- Published by Spandidos Publications in World Academy of Sciences Journal
- Vol. 8 (6) , 1-10
Open AccessGLP‑1 receptor agonists and their dental implications: A practical guide for dental practitioners (Review)
Glucagon‑like peptide‑1 receptor agonists (GLP‑1RAs) have revolutionized the management of type 2 diabetes mellitus and obesity. Their rapidly increasing use has critical implications for dental practice, yet guidance for clinicians remains limited. The aim of the present review was to provide an evidence‑based narrative summary of the oral and dental implications of GLP‑1RA therapy and to provide practical chair‑side recommendations for dental practitioners. For this purpose, a narrative literature review was performed to synthesize current evidence concerning the oral, periodontal and perioperative implications of GLP‑1RAs in dental practice. The PubMed/MEDLINE, Scopus, Web of Science and Google Scholar databases were searched for publications from January, 2015 through June, 2026. As this was a narrative review, studies were selected according to their clinical relevance and contribution to the mechanistic and practical questions addressed rather than according to a predefined systematic review protocol. No PRISMA flow diagram or quantitative study‑selection estimates were therefore applied. Particular emphasis was placed on distinguishing established clinical evidence from observational associations, preclinical findings and mechanistic hypotheses. Current evidence suggests that GLP‑1RAs may contribute to xerostomia, dysgeusia, halitosis and dental erosion, largely secondary to adverse gastrointestinal effects and salivary alterations. Conversely, improved glycemic control may favor periodontal health and wound healing. Delayed gastric emptying has critical implications for dental procedures requiring sedation or general anesthesia and necessitates careful preoperative assessment and interdisciplinary communication. On the whole, as the number of prescriptions of GLP‑1RAs continues to expand, dental practitioners should routinely identify affected patients, recognize potential oral manifestations, implement preventive strategies and consider perioperative implications to optimize patient safety and clinical outcomes.
- Open Access
- 20 July 2026
- Published by Spandidos Publications in World Academy of Sciences Journal
- Vol. 8 (5) , 1-9
Light-based technologies in dentistry: Biophotonic principles and clinical integration (Review)
Biophotonics has emerged as a transformative interdisciplinary field that integrates optical science with biological systems to enhance diagnostic and therapeutic capabilities in dentistry. Conventional diagnostic methods often detect oral diseases at advanced stages, whereas biophotonic technologies enable real-time, non-invasive and high-resolution assessments at the molecular and cellular levels. The present narrative review provides a comprehensive overview of the fundamental principles of light-tissue interactions and their clinical translation in dentistry. Key biophotonic modalities, including fluorescence imaging, optical coherence tomography, Raman spectroscopy, laser-based therapies, photodynamic therapy and photobiomodulation, are discussed with respect to their mechanisms, applications, advantages and limitations. The present review further discusses their roles across major dental specialties, such as periodontology, endodontics, restorative dentistry, orthodontics, paediatric dentistry and oral oncology. Recent advancements highlight the integration of artificial intelligence, nanotechnology and multimodal imaging systems, enabling improved diagnostic accuracy, targeted therapy and personalized treatment planning. Despite these advantages, challenges, such as limited tissue penetration, high costs, the lack of standardization, and regulatory constraints continue to restrict widespread clinical adoption. Biophotonics represents a paradigm shift toward minimally invasive, precision-based dentistry. Continued research, technological innovation and clinical validation are essential to facilitate its transition into routine dental practice and to improve overall oral healthcare outcomes.
- 20 July 2026
- Published by Spandidos Publications in World Academy of Sciences Journal
- Vol. 8 (5) , 1-9
Open AccessLight-based technologies in dentistry: Biophotonic principles and clinical integration (Review)
Biophotonics has emerged as a transformative interdisciplinary field that integrates optical science with biological systems to enhance diagnostic and therapeutic capabilities in dentistry. Conventional diagnostic methods often detect oral diseases at advanced stages, whereas biophotonic technologies enable real-time, non-invasive and high-resolution assessments at the molecular and cellular levels. The present narrative review provides a comprehensive overview of the fundamental principles of light-tissue interactions and their clinical translation in dentistry. Key biophotonic modalities, including fluorescence imaging, optical coherence tomography, Raman spectroscopy, laser-based therapies, photodynamic therapy and photobiomodulation, are discussed with respect to their mechanisms, applications, advantages and limitations. The present review further discusses their roles across major dental specialties, such as periodontology, endodontics, restorative dentistry, orthodontics, paediatric dentistry and oral oncology. Recent advancements highlight the integration of artificial intelligence, nanotechnology and multimodal imaging systems, enabling improved diagnostic accuracy, targeted therapy and personalized treatment planning. Despite these advantages, challenges, such as limited tissue penetration, high costs, the lack of standardization, and regulatory constraints continue to restrict widespread clinical adoption. Biophotonics represents a paradigm shift toward minimally invasive, precision-based dentistry. Continued research, technological innovation and clinical validation are essential to facilitate its transition into routine dental practice and to improve overall oral healthcare outcomes.
- Open Access
- 20 January 2026
- Published by F1000 Research Ltd in F1000Research
- Vol. 15, 85
Comparative Efficacy of Iontophoresis with APF Gel and Iontophoresis with Commercially Available Toothpastes (Elsenz® and Perfora) in the Management of Dentinal Hypersensitivity - A 3 months Follow-Up randomized Controlled Trial
Objectives This investigation assessed and comparedthree widely used desensitizing products— Elsenz ® toothpaste, Perfora Sensitive Toothpaste, and Fluorotop Acidulated Phosphate Fluoride (APF) gel—each paired with iontophoresis, to determine their effectiveness in alleviating dentinal hypersensitivity among adults. Materials and Methods A randomized, parallel-group clinical trial involved 27 adults aged 18–65 years, each presenting with dentinal hypersensitivity and meeting specific inclusion criteria. Participants were allocated into three treatment arms, each receiving either Elsenz, Perfora, or APF gel in conjunction with iontophoresis. Pain responses to tactile and evaporative stimuli were quantified using a visual analogue scale prior to intervention, immediately after, and at scheduled follow-ups over three months. Retreatment was offered if needed, while all participants used identical oral hygiene tools and practices throughout the study. Results All treatment groups demonstrated meaningful reductions in sensitivity. Perfora Sensitive Toothpaste combined with iontophoresis produced the swiftest and most pronounced decline in reported pain levels, frequently resolving hypersensitivity after the initial use. Elsenz ® toothpaste required repeated applications for optimal benefit, while APF gel resulted in less enduring relief compared to the alternatives. Statistical assessments confirmed significant differences favoring the Perfora group for durable symptom management. Conclusion The findings indicate that, among the products tested, Perfora Sensitive Toothpaste delivered with iontophoresis provided the most effective and lasting reduction in dentinal hypersensitivity. This outcome may be linked to its formulation and mode of application, positioning it as a strong candidate for early intervention in hypersensitivity cases. Larger-scale studies with extended observation are encouraged to confirm these promising results. The trial was prospectively registered in the Clinical Trials Registry-India (CTRI) under the registration number CTRI/2025/09/095193. The study was conducted from [03/10/2025 to 3/1/2026]. The full trial record is available at: Trial registration: CTRI/2025/09/095193.
- 20 January 2026
- Published by F1000 Research Ltd in F1000Research
- Vol. 15, 85
Open AccessComparative Efficacy of Iontophoresis with APF Gel and Iontophoresis with Commercially Available Toothpastes (Elsenz® and Perfora) in the Management of Dentinal Hypersensitivity - A 3 months Follow-Up randomized Controlled Trial
Objectives This investigation assessed and comparedthree widely used desensitizing products— Elsenz ® toothpaste, Perfora Sensitive Toothpaste, and Fluorotop Acidulated Phosphate Fluoride (APF) gel—each paired with iontophoresis, to determine their effectiveness in alleviating dentinal hypersensitivity among adults. Materials and Methods A randomized, parallel-group clinical trial involved 27 adults aged 18–65 years, each presenting with dentinal hypersensitivity and meeting specific inclusion criteria. Participants were allocated into three treatment arms, each receiving either Elsenz, Perfora, or APF gel in conjunction with iontophoresis. Pain responses to tactile and evaporative stimuli were quantified using a visual analogue scale prior to intervention, immediately after, and at scheduled follow-ups over three months. Retreatment was offered if needed, while all participants used identical oral hygiene tools and practices throughout the study. Results All treatment groups demonstrated meaningful reductions in sensitivity. Perfora Sensitive Toothpaste combined with iontophoresis produced the swiftest and most pronounced decline in reported pain levels, frequently resolving hypersensitivity after the initial use. Elsenz ® toothpaste required repeated applications for optimal benefit, while APF gel resulted in less enduring relief compared to the alternatives. Statistical assessments confirmed significant differences favoring the Perfora group for durable symptom management. Conclusion The findings indicate that, among the products tested, Perfora Sensitive Toothpaste delivered with iontophoresis provided the most effective and lasting reduction in dentinal hypersensitivity. This outcome may be linked to its formulation and mode of application, positioning it as a strong candidate for early intervention in hypersensitivity cases. Larger-scale studies with extended observation are encouraged to confirm these promising results. The trial was prospectively registered in the Clinical Trials Registry-India (CTRI) under the registration number CTRI/2025/09/095193. The study was conducted from [03/10/2025 to 3/1/2026]. The full trial record is available at: Trial registration: CTRI/2025/09/095193.
- Open Access
- 5 January 2026
- Published by Spandidos Publications in World Academy of Sciences Journal
- Vol. 8 (1) , 1-10
Silent saboteurs: Unveiling the role of viruses in periodontal disease (Review)
Periodontal diseases have long been considered primarily bacterial infections driven by the complex interplay of microbial plaque and host immune responses. However, emerging research has highlighted the significant role of viruses, particularly those from the Herpesviridae and Retroviridae families, in the pathogenesis of periodontal conditions. These viruses are not merely passive inhabitants of the oral environment; rather, they actively modulate host immunity, disrupt periodontal homeostasis and increase the pathogenic potential of coexisting bacteria. Through various mechanisms, such as immune evasion, the induction of pro‑inflammatory cytokines and the impairment of local immune surveillance, viruses can facilitate tissue destruction and exacerbate periodontal breakdown. The present narrative review aimed to comprehensively summarize the involvement of viruses in periodontal disease by delving into their structural characteristics, classification, replication strategies and intricate interactions with host immune mechanisms. Special focus is placed on herpesviruses, including Epstein‑Barr virus and human cytomegalovirus, and human immunodeficiency virus, which have been implicated in both the aggressive and chronic forms of periodontitis. Diagnostic challenges and molecular approaches for detecting these viral agents in periodontal tissues are also discussed, along with the clinical implications of their presence. Understanding the viral dimension of periodontal disease not only broadens the current knowledge of its multifactorial etiology, but also opens new avenues for the development of diagnostic, preventive and therapeutic strategies. The present review underscores the need for a paradigm shift in both the research and clinical management of periodontal diseases. The emerging role of viral diagnostics, salivary biomarkers and immunologically targeted therapies highlights the potential for more precise risk assessment and personalized periodontal care.
- 5 January 2026
- Published by Spandidos Publications in World Academy of Sciences Journal
- Vol. 8 (1) , 1-10
Open AccessSilent saboteurs: Unveiling the role of viruses in periodontal disease (Review)
Periodontal diseases have long been considered primarily bacterial infections driven by the complex interplay of microbial plaque and host immune responses. However, emerging research has highlighted the significant role of viruses, particularly those from the Herpesviridae and Retroviridae families, in the pathogenesis of periodontal conditions. These viruses are not merely passive inhabitants of the oral environment; rather, they actively modulate host immunity, disrupt periodontal homeostasis and increase the pathogenic potential of coexisting bacteria. Through various mechanisms, such as immune evasion, the induction of pro‑inflammatory cytokines and the impairment of local immune surveillance, viruses can facilitate tissue destruction and exacerbate periodontal breakdown. The present narrative review aimed to comprehensively summarize the involvement of viruses in periodontal disease by delving into their structural characteristics, classification, replication strategies and intricate interactions with host immune mechanisms. Special focus is placed on herpesviruses, including Epstein‑Barr virus and human cytomegalovirus, and human immunodeficiency virus, which have been implicated in both the aggressive and chronic forms of periodontitis. Diagnostic challenges and molecular approaches for detecting these viral agents in periodontal tissues are also discussed, along with the clinical implications of their presence. Understanding the viral dimension of periodontal disease not only broadens the current knowledge of its multifactorial etiology, but also opens new avenues for the development of diagnostic, preventive and therapeutic strategies. The present review underscores the need for a paradigm shift in both the research and clinical management of periodontal diseases. The emerging role of viral diagnostics, salivary biomarkers and immunologically targeted therapies highlights the potential for more precise risk assessment and personalized periodontal care.
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Dentistry
- Vol. 2026 (1)
Mapping the Expression Profile of MicroRNA in Peri‐Implantitis: A Scoping Review
Background: Peri‐implantitis remains a major biological complication compromising implant longevity. Conventional diagnostic tools, including clinical probing and radiographic evaluation, are limited in detecting early disease activity. MicroRNAs (miRNAs) have emerged as potential biomarkers due to their regulatory role in inflammation and bone metabolism. Objective: This scoping review aimed to map the available evidence on miRNA expression profiles in peri‐implantitis, identify knowledge gaps, and highlight miRNAs with potential diagnostic and therapeutic relevance. Methods: The review was conducted in accordance with Arksey and O’Malley’s framework, Joanna Briggs Institute guidelines, and PRISMA Extension for Scoping Review (PRISMA‐ScR) standards. Electronic databases (PubMed, Embase, and Web of Science) were searched up to October 2025. Studies evaluating miRNA expression in peri‐implantitis using human or relevant experimental samples (peri‐implant crevicular fluid [PICF], saliva, gingival tissue, serum) were included. Data were extracted and synthesized narratively. Results: Eleven studies published between 2017 and 2025 were included. Dysregulated miRNAs were consistently associated with inflammatory and osteolytic pathways, including NF‐κB, MAPK, Wnt/β‐catenin, and RANKL signaling. Downregulation of miR‐21‐3p, miR‐150‐5p, and miR‐4484, and upregulation of miR‐155 and miR‐146a were frequently reported in peri‐implantitis. Polymorphisms such as miR‐155 rs767649 and miR‐27a‐3p rs895819 were linked to disease susceptibility. However, heterogeneity in study design, small sample sizes, and lack of longitudinal validation were common limitations. Conclusion: The mapped literature indicates that miRNA expression is altered in peri‐implant disease across several biological compartments, but the evidence remains heterogeneous and largely exploratory. Specific miRNAs should be regarded as candidate biomarkers requiring independent and prospective validation rather than established diagnostic tools. Standardized sampling and analytical methods, clearly defined disease criteria, adequately powered longitudinal cohorts, and external validation are needed before clinical translation can be assessed.
- 1 January 2026
- Published by Wiley in International Journal of Dentistry
- Vol. 2026 (1)
Open AccessMapping the Expression Profile of MicroRNA in Peri‐Implantitis: A Scoping Review
Background: Peri‐implantitis remains a major biological complication compromising implant longevity. Conventional diagnostic tools, including clinical probing and radiographic evaluation, are limited in detecting early disease activity. MicroRNAs (miRNAs) have emerged as potential biomarkers due to their regulatory role in inflammation and bone metabolism. Objective: This scoping review aimed to map the available evidence on miRNA expression profiles in peri‐implantitis, identify knowledge gaps, and highlight miRNAs with potential diagnostic and therapeutic relevance. Methods: The review was conducted in accordance with Arksey and O’Malley’s framework, Joanna Briggs Institute guidelines, and PRISMA Extension for Scoping Review (PRISMA‐ScR) standards. Electronic databases (PubMed, Embase, and Web of Science) were searched up to October 2025. Studies evaluating miRNA expression in peri‐implantitis using human or relevant experimental samples (peri‐implant crevicular fluid [PICF], saliva, gingival tissue, serum) were included. Data were extracted and synthesized narratively. Results: Eleven studies published between 2017 and 2025 were included. Dysregulated miRNAs were consistently associated with inflammatory and osteolytic pathways, including NF‐κB, MAPK, Wnt/β‐catenin, and RANKL signaling. Downregulation of miR‐21‐3p, miR‐150‐5p, and miR‐4484, and upregulation of miR‐155 and miR‐146a were frequently reported in peri‐implantitis. Polymorphisms such as miR‐155 rs767649 and miR‐27a‐3p rs895819 were linked to disease susceptibility. However, heterogeneity in study design, small sample sizes, and lack of longitudinal validation were common limitations. Conclusion: The mapped literature indicates that miRNA expression is altered in peri‐implant disease across several biological compartments, but the evidence remains heterogeneous and largely exploratory. Specific miRNAs should be regarded as candidate biomarkers requiring independent and prospective validation rather than established diagnostic tools. Standardized sampling and analytical methods, clearly defined disease criteria, adequately powered longitudinal cohorts, and external validation are needed before clinical translation can be assessed.
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Dentistry
- Vol. 2026 (1)
Unlocking Therapeutic Avenues: A Comparative Study of Coconut Oil and Chlorhexidine Mouthwash Efficacy in Treating Plaque‐Induced Gingivitis During Fixed Orthodontic Treatment—A Pilot Randomized Controlled Trial
Objective: This study was done to compare the efficacy of coconut oil with that of chlorhexidine mouthwash for treating plaque‐induced gingivitis in patients receiving fixed orthodontic treatment. Material and Method: The study followed a double‐blind randomized controlled trial design. A total of 38 participants meeting specific criteria were equally allocated into two arms: Group 1 (19 participants) receiving coconut oil and Group 2 (19 participants) receiving chlorhexidine mouthwash. Plaque index (PI) and gingival index (GI) were recorded at baseline (T1), Day 7 (T2), and Day 21 (T3). Oral hygiene practices, including brushing frequency, technique, and interdental aids, were also assessed. All the statistical analyses were performed using SPSS, version 16.0, and the chi‐square and Mann‒Whitney tests were used. Results: The study found that the coconut oil group showed a statistically significant improvement ( p = 0.001) in PI scores from baseline (T1) to Day 21 (T3) of use. The GI scores in the coconut oil group also showed improvement over the 3‐week study period; however, the difference was not statistically significant. Conclusion: The findings of this study highlight that coconut oil was able to reduce plaque levels significantly and GI values nonsignificantly in those undergoing fixed orthodontic treatment. Future studies employing scientifically sound methodologies and longer follow‐ups are required to establish the effectiveness of coconut oil as a mouthwash.
- 1 January 2026
- Published by Wiley in International Journal of Dentistry
- Vol. 2026 (1)
Open AccessUnlocking Therapeutic Avenues: A Comparative Study of Coconut Oil and Chlorhexidine Mouthwash Efficacy in Treating Plaque‐Induced Gingivitis During Fixed Orthodontic Treatment—A Pilot Randomized Controlled Trial
Objective: This study was done to compare the efficacy of coconut oil with that of chlorhexidine mouthwash for treating plaque‐induced gingivitis in patients receiving fixed orthodontic treatment. Material and Method: The study followed a double‐blind randomized controlled trial design. A total of 38 participants meeting specific criteria were equally allocated into two arms: Group 1 (19 participants) receiving coconut oil and Group 2 (19 participants) receiving chlorhexidine mouthwash. Plaque index (PI) and gingival index (GI) were recorded at baseline (T1), Day 7 (T2), and Day 21 (T3). Oral hygiene practices, including brushing frequency, technique, and interdental aids, were also assessed. All the statistical analyses were performed using SPSS, version 16.0, and the chi‐square and Mann‒Whitney tests were used. Results: The study found that the coconut oil group showed a statistically significant improvement ( p = 0.001) in PI scores from baseline (T1) to Day 21 (T3) of use. The GI scores in the coconut oil group also showed improvement over the 3‐week study period; however, the difference was not statistically significant. Conclusion: The findings of this study highlight that coconut oil was able to reduce plaque levels significantly and GI values nonsignificantly in those undergoing fixed orthodontic treatment. Future studies employing scientifically sound methodologies and longer follow‐ups are required to establish the effectiveness of coconut oil as a mouthwash.
- Open Access
- 14 October 2025
- Published by Spandidos Publications in World Academy of Sciences Journal
- Vol. 7 (6) , 1-9
Hidden pitfalls: Understanding errors and complications in periodontal and implant therapy (Review)
Periodontal and implant therapies have undergone notable advancements in recent years, equipping clinicians with a diverse array of techniques and biomaterials to address both functional and aesthetic oral conditions. However, these advancements involve a spectrum of potential complications and errors that can affect treatment efficacy, patient satisfaction and long‑term outcomes. Complications can occur at any stage, from initial diagnosis and treatment planning to the intraoperative and post‑operative phases, due to factors such as inadequate case selection, anatomical challenges, procedural errors, or poor maintenance. The present narrative review provides a comprehensive and structured overview of the errors and complications associated with various aspects of periodontal and implant therapy. By understanding these issues, clinicians can better understand and prevent adverse outcomes, optimize patient care, and enhance the overall quality of periodontal and implant treatments.
- 14 October 2025
- Published by Spandidos Publications in World Academy of Sciences Journal
- Vol. 7 (6) , 1-9
Open AccessHidden pitfalls: Understanding errors and complications in periodontal and implant therapy (Review)
Periodontal and implant therapies have undergone notable advancements in recent years, equipping clinicians with a diverse array of techniques and biomaterials to address both functional and aesthetic oral conditions. However, these advancements involve a spectrum of potential complications and errors that can affect treatment efficacy, patient satisfaction and long‑term outcomes. Complications can occur at any stage, from initial diagnosis and treatment planning to the intraoperative and post‑operative phases, due to factors such as inadequate case selection, anatomical challenges, procedural errors, or poor maintenance. The present narrative review provides a comprehensive and structured overview of the errors and complications associated with various aspects of periodontal and implant therapy. By understanding these issues, clinicians can better understand and prevent adverse outcomes, optimize patient care, and enhance the overall quality of periodontal and implant treatments.
- Open Access
- 19 June 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 1481
Investigating the efficacy of hyaluronic acid in minimizing black triangles: A comprehensive analysis
In the anterior area of the mouth, the interdental papilla is important for dental hygiene and appearance. When it disappears, unpleasant “black triangles” form, which affects patients’ self-confidence in their smiles and makes oral hygiene more difficult. The loss of interdental papilla is caused by several variables such as tooth shape, periodontal disease, and aging. Although surgical treatments have been utilized to restore or retain missing papilla, their predictability remains unknown. In response, researchers have investigated non-invasive procedures, such as the use of fillers such as hyaluronic acid (HA). Owing to its capacity to increase tissue volume and bind water, HA, a naturally occurring polysaccharide with special rheological qualities, has become a popular choice for use as a dermal filler. It shows promise when used to cure interdental papilla loss; the effects usually last for six–12 months. This review article explores the development and history of papilla rebuilding methods, emphasizing hyaluronic acid as a cutting-edge and successful method for regaining both periodontal health and aesthetics.
- 19 June 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 1481
Open AccessInvestigating the efficacy of hyaluronic acid in minimizing black triangles: A comprehensive analysis
In the anterior area of the mouth, the interdental papilla is important for dental hygiene and appearance. When it disappears, unpleasant “black triangles” form, which affects patients’ self-confidence in their smiles and makes oral hygiene more difficult. The loss of interdental papilla is caused by several variables such as tooth shape, periodontal disease, and aging. Although surgical treatments have been utilized to restore or retain missing papilla, their predictability remains unknown. In response, researchers have investigated non-invasive procedures, such as the use of fillers such as hyaluronic acid (HA). Owing to its capacity to increase tissue volume and bind water, HA, a naturally occurring polysaccharide with special rheological qualities, has become a popular choice for use as a dermal filler. It shows promise when used to cure interdental papilla loss; the effects usually last for six–12 months. This review article explores the development and history of papilla rebuilding methods, emphasizing hyaluronic acid as a cutting-edge and successful method for regaining both periodontal health and aesthetics.
- Open Access
- 28 March 2025
- Published by Cumhuriyet University in Cumhuriyet Dental Journal
- Vol. 28 (1) , 122-131
Vaping and E-Cigarettes: Emerging Trends and Potential Impact on Periodontal Health- A Narrated Review
Electronic cigarettes (e-cigarettes) are battery-powered devices designed to vaporize and heat a liquid solution that typically includes nicotine. Despite recent advances, however, modern vapes have achieved the 50-year-old dream of imitating smoking while reducing the number of toxins, and future advances are bound to disrupt the current generation of electronic cigarettes. Vaping has been considered a leading risk factor for different oral pathologies and conditions, including oral cancer and periodontitis. The rapid growth in the popularity of vaping has resulted in diverse potential health consequences, many of which have the potential to affect periodontal health. Some studies indicate potential benefits in vaping concerning transitioning from traditional smoking cigarettes to vaping because of a reduced prevalence of established diseases, while others report an increased risk of periodontitis among e-cigarette smokers. Additionally, dental practitioners should be aware of the challenges associated with oral health among vape patients and educate them on the potential deterioration effects while conducting regular assessments of smoking habits.
- 28 March 2025
- Published by Cumhuriyet University in Cumhuriyet Dental Journal
- Vol. 28 (1) , 122-131
Open AccessVaping and E-Cigarettes: Emerging Trends and Potential Impact on Periodontal Health- A Narrated Review
Electronic cigarettes (e-cigarettes) are battery-powered devices designed to vaporize and heat a liquid solution that typically includes nicotine. Despite recent advances, however, modern vapes have achieved the 50-year-old dream of imitating smoking while reducing the number of toxins, and future advances are bound to disrupt the current generation of electronic cigarettes. Vaping has been considered a leading risk factor for different oral pathologies and conditions, including oral cancer and periodontitis. The rapid growth in the popularity of vaping has resulted in diverse potential health consequences, many of which have the potential to affect periodontal health. Some studies indicate potential benefits in vaping concerning transitioning from traditional smoking cigarettes to vaping because of a reduced prevalence of established diseases, while others report an increased risk of periodontitis among e-cigarette smokers. Additionally, dental practitioners should be aware of the challenges associated with oral health among vape patients and educate them on the potential deterioration effects while conducting regular assessments of smoking habits.